Botanical species · safety record

Fumaria indica

The EFSA Compendium of Botanicals holds 5 constituent measurements for Fumaria indica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Fumaria indica (Hausskn.) Pugsley

5Constituent measurements

0Safety records

3Cited sources

4Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 4 licensed products naming Fumaria indica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Whole plant
Whole plant(s)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Fuyuziphine	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Hydrastine	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Fumarizine	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Isoquinoline alkaloids	Unspecified	Solvent extraction	≤ 398 Milligram/100 gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Isoquinoline alkaloids	Unspecified	Solvent extraction	≥ 136 Milligram/100 gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Tripathi, Y C., Rathore, M., Kumar, H. On the variation of alkaloidal contents of fumaria indica at different stages of life span.. Ancient science of life, 1994, vol. 13, no. 3-4, p. 271-3.
Pandey, M. B., Singh, A. K., Singh, J. P., Singh, V. P., Pandey, V. B. Fuyuziphine, a new alkaloid from Fumaria indica. NATURAL PRODUCT RESEARCH, 2008, vol. 22, no. 6, p. 533-536. DOI
Atta-Ur-Rahman., Ali, S.S., Qureshi, M.M., Hassan, S., Bhati, K. Fumarizine - A new benzylisoquinoline alkaloid from Fumaria indica. Fitoterapia, 1989, vol. 60, no. 6, p. 552-553.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature